Analyses (145 completed)

Investigate the therapeutic potential of clearing senescent cells (senolytics) to slow or reverse neurodegeneration. Key questions: 1. Which senescent cell types in the brain con...

Analyze circuit-level changes in neurodegeneration using Allen Institute Neural Dynamics data. Focus on: (1) hippocampal circuit disruption, (2) cortical dynamics alterations, (3) ...

What gene expression changes in the aging mouse brain predict neurodegenerative vulnerability? Use Allen Aging Mouse Brain Atlas data. Cross-reference with human AD datasets. Produ...

The disease-associated microglia (DAM) phenotype involves TREM2 upregulation, but whether therapeutic agonism or antagonism of TREM2 is beneficial remains contested across disease ...

While the study demonstrates dose-response relationships between amyloid levels and outcomes, it doesn't establish specific threshold values for clinical benefit. Defining these th...

Investigate how lipid raft composition (cholesterol metabolism, sphingolipids) changes in synaptic membranes during neurodegeneration and their mechanistic role in amyloid-beta pro...

Analyze how neuroinflammatory cascades disrupt blood-brain barrier (BBB) integrity through tight junction protein degradation. Key mechanisms to investigate: 1. TNF-alpha signalin...

Investigate mechanisms of epigenetic reprogramming in aging neurons, including DNA methylation changes, histone modification dynamics, chromatin remodeling, and partial reprogrammi...

Senolytics targeting p16/p21+ senescent astrocytes and microglia may reduce SASP-driven neuroinflammation.

The abstract explicitly questions whether AD's hallmark pathologies induce cholinergic dysfunction or vice versa. This fundamental causality question is critical for determining th...

While ketone metabolism was discussed as therapeutic, the debate revealed no clear framework for when and how much ketosis provides benefit vs harm. The 'metabolic steal syndrome' ...

Multiple NDDs converge on autophagy-lysosome dysfunction. Are there universal therapeutic targets?

Mechanistic role of APOE in neurodegeneration?

The debate highlighted a critical dosing paradox where both hypo- and hypermethylation could be harmful, but no clear boundaries were established. This knowledge gap prevents safe ...

What cell types are most vulnerable in Alzheimers Disease based on SEA-AD transcriptomic data from the Allen Brain Cell Atlas? Identify mechanisms of cell-type-specific vulnerabili...

The debate discussed various metabolic interventions but lacked clear endpoints for clinical translation. Without validated biomarkers linking metabolic changes to neuronal surviva...

Investigate prion-like spreading of tau pathology through connected brain regions, focusing on trans-synaptic transfer, extracellular vesicle-mediated spread, and intervention stra...

Despite the debate focusing on SEA-AD transcriptomic data, no actual gene expression patterns or pathway analyses from this dataset were presented. The fundamental question of whic...

The debate identified a critical therapeutic window when astrocytic ketone production declines but neurons retain oxidation capacity, but the exact timing and molecular triggers re...

Evaluate the potential of CRISPR/Cas9 and related gene editing technologies for treating neurodegenerative diseases including Alzheimer disease, Parkinson disease, Huntington disea...

While TREM2 was identified as critical for microglial senescence, the debate lacked fine-grained temporal data on when and how TREM2 signaling shifts from neuroprotective to pathog...

APOE4 differs from APOE3 by C112R causing domain interaction that alters lipid binding and amyloid clearance.

The debate highlighted that G2019S shows elevated baseline RAB10 phosphorylation, but it's unclear whether this represents true signal amplification during lysosomal swelling or ju...

SPMs (resolvins, protectins, maresins) from omega-3s may promote inflammation resolution. Are resolution failures druggable?

Anti-amyloid antibodies (lecanemab, donanemab) have ~0.1% brain penetrance. Engineering improved BBB transcytosis via transferrin receptor, LRP1, or novel shuttle peptides could dr...